MedPath

Risperdal

Brand Name: Risperdal

Generic Name: Risperidone

Active
Registration Number

DR-XY40690

Dosage Form

Tablet

Issuance Date

February 28, 2022

Expiry Date

February 27, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength2 mg
PackagingBlister pack x 10's

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antipsychotic
A
Application
Automatic Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

RisperidoneActive
Monograph: Risperidone

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform